title: Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis.
abstract: Catheter-associated urinary tract infections (CAUTIs) represent the most common type of nosocomial infection and are a major health concern due to the complications and frequent recurrence. These infections are often caused by Escherichia coli and Proteus mirabilis. Gram-negative bacterial species that cause CAUTIs express a number of virulence factors associated with adhesion, motility, biofilm formation, immunoavoidance, and nutrient acquisition as well as factors that cause damage to the host. These infections can be reduced by limiting catheter usage and ensuring that health care professionals correctly use closed-system Foley catheters. A number of novel approaches such as condom and suprapubic catheters, intermittent catheterization, new surfaces, catheters with antimicrobial agents, and probiotics have thus far met with limited success. While the diagnosis of symptomatic versus asymptomatic CAUTIs may be a contentious issue, it is generally agreed that once a catheterized patient is believed to have a symptomatic urinary tract infection, the catheter is removed if possible due to the high rate of relapse. Research focusing on the pathogenesis of CAUTIs will lead to a better understanding of the disease process and will subsequently lead to the development of new diagnosis, prevention, and treatment options.
authors.affiliation: Department of Biomedical Sciences, Dental School, University of Maryland-Baltimore, Room 9209, 650 W. Baltimore Street, Baltimore, MD 21201, USA.
authors.forename: S M
authors.initials: SM
authors.lastname: Jacobsen
authors.forename: D J
authors.initials: DJ
authors.lastname: Stickler
authors.forename: H L T
authors.initials: HL
authors.lastname: Mobley
authors.forename: M E
authors.initials: ME
authors.lastname: Shirtliff
mesh_terms: D000222:Adaptation, Physiological; D018829:Adhesins, Bacterial; D018441:Biofilms / Q000254:growth & development; D002404:Catheterization / Q000639:trends; D003428:Cross Infection / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D004926:Escherichia coli / Q000502:physiology*; D004927:Escherichia coli Infections / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D006801:Humans; D008124:Locomotion; D011379:Prognosis; D011512:Proteus Infections / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D011513:Proteus mirabilis / Q000502:physiology*; D013672:Technology; D014546:Urinary Catheterization / Q000009:adverse effects* / Q000592:standards; D014552:Urinary Tract Infections / Q000175:diagnosis / Q000209:etiology / Q000628:therapy
chemical_list: D018829:Adhesins, Bacterial